3rd Quarter - Report
ADAPTIVE BIOTECHNOLOGIES for ADAPTIVE BIOTECHNOLOGIES
Client
Income
—
Expenses
$140,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Issues related to T-cells, COVID testing, and immune medicine
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAMELA LYNN BRADLEY | — |
Health Issues HCR
Issues related to T cells, COVID testing, and immune medicine. H.R. 6102 and S.3404, The Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2020, all provisions
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAMELA LYNN BRADLEY | covered legislative branch official |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.